BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Gong EJ, Lee JY, Bae SE, Park YS, Choi KD, Song HJ, Lee GH, Jung HY, Jeong WJ, Cheon GJ, Yook JH, Kim BS. Characteristics of non-cardia gastric cancer with a high serum anti-Helicobacter pylori IgG titer and its association with diffuse-type histology.PLoS One. 2018;13:e0195264. [PMID: 29621300 DOI: 10.1371/journal.pone.0195264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Ansari S, Gantuya B, Tuan VP, Yamaoka Y. Diffuse Gastric Cancer: A Summary of Analogous Contributing Factors for Its Molecular Pathogenicity. Int J Mol Sci 2018;19:E2424. [PMID: 30115886 DOI: 10.3390/ijms19082424] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
2 Li S, Yu C, Cheng Y, Du F, Wen G. Bioinformatics analysis identifies biomarkers associated with poor prognosis in diffuse‑type gastric cancer. Mol Med Rep 2021;23:193. [PMID: 33495829 DOI: 10.3892/mmr.2021.11832] [Reference Citation Analysis]
3 Kang S, Park M, Cho JY, Ahn SJ, Yoon C, Kim SG, Cho SJ. Tumorigenic mechanisms of estrogen and Helicobacter pylori cytotoxin-associated gene A in estrogen receptor α-positive diffuse-type gastric adenocarcinoma. Gastric Cancer 2022. [PMID: 35391613 DOI: 10.1007/s10120-022-01290-0] [Reference Citation Analysis]
4 Choi Y, Kim N, Kim KW, Jo HH, Park J, Yoon H, Shin CM, Park YS, Lee DH, Oh HJ, Lee HS, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH, Kim JW, Kim JW, Lee KW, Chang W, Park JH, Lee YJ, Lee KH, Kim YH. Sex-based differences in histology, staging, and prognosis among 2983 gastric cancer surgery patients. World J Gastroenterol 2022; 28(9): 933-947 [DOI: 10.3748/wjg.v28.i9.933] [Reference Citation Analysis]
5 Song L, Song M, Rabkin CS, Williams S, Chung Y, Van Duine J, Liao LM, Karthikeyan K, Gao W, Park JG, Tang Y, Lissowska J, Qiu J, LaBaer J, Camargo MC. Helicobacter pylori Immunoproteomic Profiles in Gastric Cancer. J Proteome Res 2021;20:409-19. [PMID: 33108201 DOI: 10.1021/acs.jproteome.0c00466] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
6 Senchukova MA, Tomchuk O, Shurygina EI. Helicobacter pylori in gastric cancer: Features of infection and their correlations with long-term results of treatment. World J Gastroenterol 2021;27:6290-305. [PMID: 34712033 DOI: 10.3748/wjg.v27.i37.6290] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Li X, Zhu X, Wang Y, Wang R, Wang L, Zhu ML, Zheng L. Prognostic value and association of Lauren classification with VEGF and VEGFR-2 expression in gastric cancer. Oncol Lett 2019;18:4891-9. [PMID: 31611999 DOI: 10.3892/ol.2019.10820] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
8 Morais S, Costa A, Albuquerque G, Araújo N, Tsugane S, Hidaka A, Hamada GS, Ye W, Plymoth A, Leja M, Gasenko E, Zaridze D, Maximovich D, Malekzadeh R, Derakhshan MH, Pelucchi C, Negri E, Camargo MC, Curado MP, Vioque J, Zhang ZF, La Vecchia C, Boffetta P, Lunet N. "True" Helicobacter pylori infection and non-cardia gastric cancer: A pooled analysis within the Stomach Cancer Pooling (StoP) Project. Helicobacter 2022;:e12883. [PMID: 35235224 DOI: 10.1111/hel.12883] [Reference Citation Analysis]